000			02197 a2200505 4500
005			20250514021157.0
264		0	_c20020520
008			200205s 0 0 eng d
022			_a1473-0502
024	7		_a10.1016/s1473-0502(01)00097-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aWeinstein, R
245	0	0	_aA period of trial in American apheresis medicine. _h[electronic resource]
260			_bTransfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis _cOct 2001
300			_a89-91 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAdrenal Cortex Hormones _xtherapeutic use
650	0	4	_aAdrenocorticotropic Hormone _xtherapeutic use
650	0	4	_aAdult
650	0	4	_aAmbulatory Care _xeconomics
650	0	4	_aAutoimmune Diseases _xdrug therapy
650	0	4	_aBlood Component Removal _xeconomics
650	0	4	_aCenters for Medicare and Medicaid Services, U.S.
650	0	4	_aChorea _xtherapy
650	0	4	_aClinical Trials as Topic
650	0	4	_aCombined Modality Therapy
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aDouble-Blind Method
650	0	4	_aEvidence-Based Medicine
650	0	4	_aHumans
650	0	4	_aImmunoglobulins, Intravenous _xtherapeutic use
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aInsurance, Health, Reimbursement _xeconomics
650	0	4	_aMultiple Sclerosis _xdrug therapy
650	0	4	_aMyelitis, Transverse _xdrug therapy
650	0	4	_aObsessive-Compulsive Disorder _xtherapy
650	0	4	_aOutpatient Clinics, Hospital _xeconomics
650	0	4	_aPlasma Exchange _xeconomics
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aReimbursement Mechanisms _xorganization & administration
650	0	4	_aTreatment Outcome
650	0	4	_aUnited States
773	0		_tTransfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis _gvol. 25 _gno. 2 _gp. 89-91
856	4	0	_uhttps://doi.org/10.1016/s1473-0502(01)00097-0 _zAvailable from publisher's website
999			_c11673400 _d11673400